Lipoflex Special, Infusionsvæske

A mixture of essential and non‑essential amino acids, the active ingredients in Lipoflex Special, Infusionsvæske, is a nutrition supplement presented as an intravenous solution for parenteral use. It provides amino acids for patients who cannot meet protein needs through oral or enteral feeding, such as those in critical care, post‑operative recovery, or with severe malnutrition.

GNH USA supplies Lipoflex Special, Infusionsvæske as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive care units worldwide.

Lipoflex Special, Infusionsvæske is used in parenteral nutrition to support protein synthesis and metabolic needs in patients with compromised oral intake.

Severe malnutrition: supplies essential amino acids to meet protein requirements when oral feeding is not possible. Post‑operative recovery: aids tissue repair and nitrogen balance after major surgery. Critical illness/ICU patients: provides rapid amino acid delivery for patients on mechanical ventilation or with catabolic stress. Burn injuries: supports high protein turnover and wound healing in extensive burn cases.

Lipoflex Special, Infusionsvæske may be associated with several adverse reactions.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Mild infusion site irritation or erythema. - Electrolyte disturbances such as mild hypokalemia. - Nausea or transient vomiting. - Transient increase in serum urea. - Mild headache.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Metabolic acidosis due to amino acid overload. - Severe hypernatremia or hyperosmolar states. - Acute renal failure in susceptible patients. - Thrombophlebitis at the infusion site. - Severe electrolyte imbalances requiring immediate intervention.

When using Lipoflex Special, Infusionsvæske, clinicians should observe several safety measures.

Assess renal function: adjust amino acid load in patients with impaired kidney function. Monitor blood glucose: patients with diabetes may require tighter glycaemic control. Check electrolytes: regular monitoring of potassium, sodium, and calcium levels is advised. Avoid incompatibility: do not mix with calcium‑containing solutions to prevent precipitation. Observe infusion rate: administer according to prescribed rate to reduce risk of metabolic complications. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipoflex Special, Infusionsvæske can interact with other intravenous agents and systemic medications.

Major Interactions (Avoid): - Calcium‑containing solutions: may precipitate amino acids, causing line occlusion. - High‑dose potassium chloride: risk of severe hyperkalemia. - Certain antibiotics (e.g., aminoglycosides): may increase nephrotoxicity when combined.

Moderate Interactions (Monitor Closely): - Concurrent glucose infusion: monitor for hyperglycemia. - Loop diuretics: watch electrolyte balance, especially potassium. - Corticosteroids: may enhance catabolic effects, requiring dosage adjustment. - Anticoagulants: monitor coagulation parameters as protein load can affect plasma volume.